| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/JAMA.272.18.1413 |
| P2093 | author name string | J. M. Seddon | |
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vitamin | Q34956 |
| eye disease | Q3041498 | ||
| P304 | page(s) | 1413-1420 | |
| P577 | publication date | 1994-11-09 | |
| P1433 | published in | The Journal of the American Medical Association | Q1470970 |
| P1476 | title | Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group | |
| P478 | volume | 272 |
| Q43604478 | A European carotenoid database to assess carotenoid intakes and its use in a five-country comparative study. |
| Q43213454 | A large scale method for preparation of plant thylakoids for use in body weight regulation. |
| Q33263803 | A review of drug options in age-related macular degeneration therapy and potential new agents |
| Q34658953 | A2E and blue light in the retina: the paradigm of age-related macular degeneration |
| Q58279836 | Age-Related Macular Degeneration: A Review for Health Educators |
| Q32004815 | Age-related macular degeneration: a review of experimental treatments |
| Q38330232 | An Evidence-Based Systematic Review of Lutein by the Natural Standard Research Collaboration |
| Q34784437 | An innovative approach to the determination of safety for a dietary ingredient derived from a new source: case study using a crystalline lutein product |
| Q37018870 | Anecortave acetate in the treatment of age-related macular degeneration. |
| Q36179770 | Anti-oxidant therapy: does it have a role in the treatment of human disease? |
| Q39977823 | Assessment of dietary lutein, zeaxanthin and lycopene intakes and sources in the Spanish survey of dietary intake (2009-2010). |
| Q44149258 | Assessment of the ability of the antioxidant cocktail-derived from fermentation of plants with effective microorganisms (EM-X) to modulate oxidative damage in the kidney and liver of rats in vivo: studies upon the profile of poly- and mono-unsaturat |
| Q36093266 | Association of macular pigment optical density with risk factors for wet age-related macular degeneration in the Indian population |
| Q37588925 | Association of the Intestinal Microbiome with the Development of Neovascular Age-Related Macular Degeneration. |
| Q28235987 | Associations between lutein, zeaxanthin, and age-related macular degeneration: an overview |
| Q73693823 | Beta-carotene and protein oxidation: effects of ascorbic acid and alpha-tocopherol |
| Q40234151 | Cadmium exposure and age-related macular degeneration |
| Q34181790 | Carotenoid composition and vitamin A value in ají (Capsicum baccatum L.) and rocoto (C. pubescens R. & P.), 2 pepper species from the Andean region |
| Q37125125 | Carotenoid intakes, assessed by food-frequency questionnaires (FFQs), are associated with serum carotenoid concentrations in the Jackson Heart Study: validation of the Jackson Heart Study Delta NIRI Adult FFQs. |
| Q38034261 | Carotenoid lutein: a promising candidate for pharmaceutical and nutraceutical applications |
| Q58487577 | Carotenoids and protection of phospholipids in solution or in liposomes against oxidation by peroxyl radicals: Relationship between carotenoid structure and protective ability |
| Q41721713 | Carotenoids: biology and treatment |
| Q35008835 | Carotenoids: separation methods applicable to biological samples |
| Q34272298 | Cell transplantation as a treatment for retinal disease |
| Q43604472 | Changes in plasma antioxidant status following consumption of diets high or low in fruit and vegetables or following dietary supplementation with an antioxidant mixture |
| Q30642886 | Changing therapeutic paradigms for exudative age-related macular degeneration: antiangiogenic agents and photodynamic therapy |
| Q54392848 | Complement factor H Y402H gene polymorphism and response to intravitreal bevacizumab in exudative age-related macular degeneration. |
| Q34272304 | Confronting complexity: the interlink of phototransduction and retinoid metabolism in the vertebrate retina |
| Q33848201 | Design of Physicians' Health Study II--a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials |
| Q44238476 | Dietary antioxidant intake and incidence of early age-related maculopathy: the Blue Mountains Eye Study |
| Q33695980 | Do age-related macular degeneration and cardiovascular disease share common antecedents? |
| Q38963195 | Dye solutions based on lutein and zeaxanthin: in vitro and in vivo analysis of ocular toxicity profiles. |
| Q35030776 | Eating well: ageing gracefully! |
| Q40812272 | Effect of lutein and antioxidant supplementation on VEGF expression, MMP-2 activity, and ultrastructural alterations in apolipoprotein E-deficient mouse. |
| Q36280084 | Effects of Lutein and Zeaxanthin on LPS-Induced Secretion of IL-8 by Uveal Melanocytes and Relevant Signal Pathways |
| Q37575638 | Establishment of a Method for Measuring Antioxidant Capacity in Urine, Based on Oxidation Reduction Potential and Redox Couple I2/KI. |
| Q35552553 | Evidence of association of APOE with age-related macular degeneration: a pooled analysis of 15 studies |
| Q47116595 | Evolution, Development and Function of Vertebrate Cone Oil Droplets |
| Q36787618 | Fruits of the actinidia genus |
| Q40832209 | Functional food science and defence against reactive oxidative species |
| Q34027771 | Genetic profile for five common variants associated with age-related macular degeneration in densely affected families: a novel analytic approach |
| Q34194244 | Haematococcus astaxanthin: applications for human health and nutrition |
| Q34577962 | Improvement of dry eye symptoms with polyunsaturated fatty acids |
| Q46352349 | In vitro effects of vitamin supplements on platelet-activating factor and its metabolism in age-related macular degeneration |
| Q39533399 | Increased Macular Pigment Optical Density and Visual Acuity following Consumption of a Buttermilk Drink Containing Lutein-Enriched Egg Yolks: A Randomized, Double-Blind, Placebo-Controlled Trial |
| Q44268957 | Influence of short-term antioxidant supplementation on macular function in age-related maculopathy: a pilot study including electrophysiologic assessment. |
| Q74566504 | Laser photocoagulation of confluent soft macular drusen |
| Q50151446 | Lipofuscin-mediated photic stress inhibits phagocytic activity of ARPE-19 cells; effect of donors' age and antioxidants. |
| Q46262751 | Long-term plant stanol and sterol ester-enriched functional food consumption, serum lutein/zeaxanthin concentration and macular pigment optical density |
| Q26773085 | Lutein, Zeaxanthin, and meso-Zeaxanthin in the Clinical Management of Eye Disease |
| Q43571470 | Macular pigment optical density in a midwestern sample |
| Q35130862 | Macular pigment optical density measurements: evaluation of a device using heterochromatic flicker photometry |
| Q34683188 | Macular pigment: influences on visual acuity and visibility |
| Q37349992 | Macular zeaxanthins and lutein -- a review of dietary sources and bioavailability and some relationships with macular pigment optical density and age-related macular disease |
| Q38883806 | Methods for a population-based study of the prevalence of and risk factors for age-related maculopathy and macular degeneration in elderly European populations: the EUREYE study. |
| Q44110946 | Neovascular age-related macular degeneration and its relationship to antioxidant intake |
| Q30662463 | Ocular perfusion and age-related macular degeneration. |
| Q33871212 | Post-translational protein modification by carotenoid cleavage products. |
| Q37644316 | Potatoes and human health |
| Q34491498 | Prevention of age-related macular degeneration |
| Q46905342 | Processed and prepared corn products as sources of lutein and zeaxanthin: compositional variation in the food chain |
| Q30751461 | Progress in measurement of ocular blood flow and relevance to our understanding of glaucoma and age-related macular degeneration. |
| Q30858951 | Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients |
| Q24545563 | Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3 |
| Q31926371 | Risk factors for age-related macular degeneration |
| Q36050310 | Skin carotenoid status measured by resonance Raman spectroscopy as a biomarker of fruit and vegetable intake in preschool children |
| Q34394380 | Smoking and age-related macular degeneration: review and update |
| Q26769895 | The Photobiology of Lutein and Zeaxanthin in the Eye |
| Q64050071 | The association between cigarette smoking and ocular diseases |
| Q34421711 | The evolving role of carotenoids in human biochemistry |
| Q42691402 | The rate of myocardial infarction events among patients with age-related macular degeneration: a population-based study |
| Q34060719 | The role of oxidative stress in the pathogenesis of age-related macular degeneration. |
| Q24802193 | The role of the carotenoids, lutein and zeaxanthin, in protecting against age-related macular degeneration: a review based on controversial evidence |
| Q37261208 | Zeaxanthin Induces Apoptosis in Human Uveal Melanoma Cells through Bcl-2 Family Proteins and Intrinsic Apoptosis Pathway |
| Q41843418 | Zeaxanthin inhibits hypoxia-induced VEGF secretion by RPE cells through decreased protein levels of hypoxia-inducible factors-1α. |
| Q26765250 | Zeaxanthin: Review of Toxicological Data and Acceptable Daily Intake |
Search more.